Navigation Links
Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference
Date:9/13/2010

CAMBRIDGE, Mass., Sept. 13 /PRNewswire/ -- Merrimack Pharmaceuticals today announced that it will present at the Stifel Nicolaus 2010 Healthcare Conference in Boston. William Sullivan, Vice President of Finance, will provide a company overview at 11:30am, EDT, Friday, September 17, 2010 at the Four Seasons Hotel in Boston, Massachusetts.

(Logo: http://photos.prnewswire.com/prnh/20100913/NE63515LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100913/NE63515LOGO)

About MerrimackMerrimack Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel medicines for the treatment of cancer and inflammation. The Company is advancing a robust pipeline of engineered therapeutics paired with molecular diagnostics. Merrimack has three oncology candidates in clinical development: MM-121, partnered with sanofi-aventis, in Phase 2 clinical testing, MM-111 in Phase 1/2 clinical testing, MM-398, partnered with PharmaEngine, Inc., in Phase 2 clinical testing and multiple pre-clinical development and research stage programs in the pipeline. MM-121, MM-111, and MM-398 are investigational drugs and have not been approved by the U.S. Food and Drug Administration or any international regulatory agency. The Company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, integrates the fields of engineering, biology and computing to enable mechanism-based model driven discovery and development of both therapeutics and diagnostics. Merrimack is a privately-held company based in Cambridge, Massachusetts. For additional information, please visit http://www.merrimackpharma.com. ContactsKathleen Petrozzelli, Corporate Communications, 617-441-1043, kpetrozzelli@merrimackpharma.com, http://www.merrimackpharma.com Betsy Ra
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
2. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: Global Patient Scales Industry ... report analyzes the worldwide markets for Patient Scales ... Floor Scales, Infant & Baby Scales, Chair Scales, ... comprehensive analytics for the US, Canada, Japan, Europe, ...
(Date:8/19/2014)...   Lincor Inc. today announced an ... New Jersey -based healthcare system ... will deploy Lincor,s PatientLINC technology across its three-hospital ... Hoboken University Medical Center. Lincor,s LINC ... to help hospitals reach new levels of patient ...
(Date:8/19/2014)... 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick ... describing an innovative diagnostic procedure for the detection of ... on Disease (SPEC) conference in Krakow, Poland ... "Development of in vitro Diagnostics for Detection of Colorectal ... the conference poster session on Tuesday, August 19, 2014 ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
(Date:8/20/2014)... Thompson HealthDay Reporter WEDNESDAY, ... older women avoid a condition that causes a life-threatening irregular ... had a 10 percent lower risk of developing atrial fibrillation, ... the Aug. 20 issue of the Journal of the ... against the heart rhythm disorder even if they were obese, ...
(Date:8/20/2014)... Park Cities Pet Sitter , Inc. has announced ... donation drive that benefits the animal shelter and rescue communities. ... with the Humane Society of the United States’ Animal Shelter ... , As part of their participation, Park Cities Pet Sitter ... the Presents 4 Pets drive from their client base, as ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 With 3943.8% growth, ... list of the nation’s fastest growing companies. The Inc. 500 ... health care sector. Connexion Point is the #1 fastest growing ... in Medicare and Medicaid, and its clients include four of ... Point employs 1,000 people and has offices and contact centers ...
(Date:8/20/2014)... common cause of endophthalmitis, a potentially blinding condition that ... injections, are the well-known staphylococci ("staph") and ... study published in the August issue of Ophthalmology ... of cases at New York Eye and Ear Infirmary ... found that gram-positive bacteria, which include staph and strep ...
(Date:8/20/2014)... August 20, 2014 The non-small cell ... considerably in the offing across the top 8 developed ... 2013 to around USD 8 billion by 2020-end, posting ... growth is projected to be driven by innovative therapies ... currently lacking efficient treatment, unlike the non-squamous segment. Thus, ...
Breaking Medicine News(10 mins):Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4
... , CINCINNATI , Feb. ... works through the immune system to regenerate damaged kidney tissues ... a number of organs. , The findings, reported in this ... from collaborative research led by Cincinnati Children,s Hospital Medical Center ...
... narcolepsy Individuals with the sleep disorder narcolepsy suffer ... by strong emotions (a condition known as cataplexy). It is ... it is caused by the individual,s immune system attacking certain ... been proven definitively. However, Mehdi Tafti and colleagues, at the ...
... buttons to stop closing doors , MONDAY, Feb. 15 ... injuries each year in the United States, and three-quarters of ... large-scale study of these events. , Slips, trips and falls ... one-third were caused by elevator doors closing on a person. ...
... bariatric procedures, use of revisions will grow, study finds ... surgery carries a higher risk of complications than the ... surgical treatment, known as bariatric surgery, is the only ... people. Rates of repeat bariatric surgery are reported to ...
... , RESTON, Va. , Feb. 15 ... digital world, today released a study of online health insurance activity in ... insurance site in Q4 2009, representing 10 percent of the total U.S. ... the complimentary comScore webinar, The Online Health Insurance Landscape, on ...
... them as new treatments for heart disease, other conditions ... identified several drugs that can change the way cells ... used to treat heart attack, stroke and other conditions. ... naturally during development and in response to demanding activities ...
Cached Medicine News:Health News:Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair 2Health News:Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair 3Health News:JCI online early table of contents: Feb. 15, 2010 2Health News:JCI online early table of contents: Feb. 15, 2010 3Health News:JCI online early table of contents: Feb. 15, 2010 4Health News:JCI online early table of contents: Feb. 15, 2010 5Health News:JCI online early table of contents: Feb. 15, 2010 6Health News:Elevators Can Bring Injury to Seniors 2Health News:Repeated Weight-Loss Surgery Carries Added Risks 2Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 2Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 3Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 4Health News:Drugs That Shift Cell's Energy Find New Purpose 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: